ABIONYX Pharma vs Efferon
ABIONYX Pharma vs Efferon, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and Efferon on 45/100.
Where each one leads
ABIONYX Pharma
- funding raised: $225M against $17.5M
Efferon
- agent readiness: 52/100 against 43/100
- domain rating: 30/100 against 25/100
At a glance
| Measure | ABIONYX Pharma | Efferon |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative therapies for sepsis and intensive care. | Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Medical Devices, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Hardware |
| Founded | 2015 | 2017 |
| Headquarters | Toulouse, France | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | ABIONYX Pharma | Efferon |
|---|---|---|
| Total funding | $225M | $17.5M |
| Latest round | Capital Increase | Seed |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ABIONYX Pharma | Efferon |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 45/100 |
| Traction | 40/100 | 36/100 |
| Team | 20/100 | 30/100 |
| Search visibility | 5/100 | 15/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | D (52/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ABIONYX Pharma | Efferon |
|---|---|---|
| Hosting | Self Managed | Vercel |
| CDN | Not detected | Vercel |
| CMS | Not detected | Ghost |
| Frameworks | Jquery | Next.js |
| Analytics | Google Analytics 4 | Not detected |
ABIONYX Pharma vs Efferon: common questions
Which is better, ABIONYX Pharma or Efferon?
On our 0-100 score Efferon rates higher (45/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do ABIONYX Pharma and Efferon compare on the numbers?
ABIONYX Pharma leads on funding raised ($225M against $17.5M). Efferon leads on agent readiness (52/100 against 43/100), domain rating (30/100 against 25/100).
Read the full ABIONYX Pharma review and pricing or the Efferon review and pricing. You can also browse other ABIONYX Pharma alternatives we track.